Search Results - "WAGNER, L. M"

Refine Results
  1. 1

    Cytotoxic effect of Argentine medicinal plant extracts on human hepatocellular carcinoma cell line by RUFFA, M. J, FERRARO, G, WAGNER, M. L, CALCAGNO, M. L, CAMPOS, R. H, CAVALLARO, L

    Published in Journal of ethnopharmacology (01-03-2002)
    “…Methanolic extracts from Achyrocline satureioides (Dc.) Lam, Aristolochia macroura Gomez, Lithraea molleoides (Vell.) Engl., Schinus molle L., unlike those…”
    Get full text
    Journal Article
  2. 2

    Beyond benzodiazepines: alternative pharmacologic agents for the treatment of insomnia by Wagner, J, Wagner, ML, Hening, WA

    Published in The Annals of pharmacotherapy (01-06-1998)
    “…OBJECTIVE: To review the epidemiology, etiology, and classification of insomnia and provide an overview of the pharmacologic therapy of insomnia. Novel…”
    Get full text
    Journal Article
  3. 3

    Hepatosplenic Cat-Scratch Disease in Children: Selected Clinical Features and Treatment by Arisoy, E. Sami, Correa, Armando G., Wagner, Milton L., Kaplan, Sheldon L.

    Published in Clinical infectious diseases (01-04-1999)
    “…We reviewed 19 cases of hepatosplenic cat-scratch disease at Texas Children's Hospital (Houston). The range of the patients' ages was 2 years 4 months to 11…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo by WALTERS, A. S, WAGNER, M. L, HENING, W. A, GRASING, K, MILLS, R, SUDHANSU CHOKROVERTY, KAVEY, N

    Published in Sleep (New York, N.Y.) (01-06-1993)
    “…In a double-blind randomized crossover trial, oxycodone or placebo was given in divided night-time doses to 11 patients with idiopathic restless legs syndrome…”
    Get full text
    Journal Article
  5. 5

    Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome by WAGNER, M. L, WALTERS, A. S, COLEMAN, R. G, HENING, W. A, GRASING, K, CHOKROVERTY, S

    Published in Sleep (New York, N.Y.) (1996)
    “…Ten patients with idiopathic restless leg syndrome (RLS) were asked to rate their symptoms at baseline during 2 weeks of placebo and 2 weeks of clonidine…”
    Get full text
    Journal Article
  6. 6

    Impact of a Falls Menu-Driven Incident-Reporting System on Documentation and Quality Improvement in Nursing Homes by Wagner, Laura M., Capezuti, Elizabeth, Taylor, Jo A., Sattin, Richard W., Ouslander, Joseph G.

    Published in The Gerontologist (01-12-2005)
    “…Purpose: Data from incident-reporting systems have been used successfully in disciplines other than health care to improve safety. This study tested the effect…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Genetic risk factors for insidious equine recurrent uveitis in Appaloosa horses by Fritz, K. L., Kaese, H. J., Valberg, S. J., Hendrickson, J. A., Rendahl, A. K., Bellone, R. R., Dynes, K. M., Wagner, M. L., Lucio, M. A., Cuomo, F. M., Brinkmeyer-Langford, C. L., Skow, L. C., Mickelson, J. R., Rutherford, M. S., McCue, M. E.

    Published in Animal genetics (01-06-2014)
    “…Summary Appaloosa horses are predisposed to equine recurrent uveitis (ERU), an immune‐mediated disease characterized by recurring inflammation of the uveal…”
    Get full text
    Journal Article
  9. 9

    Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein by Kim, Y U, Kinoshita, T, Molina, H, Hourcade, D, Seya, T, Wagner, L M, Holers, V M

    Published in The Journal of experimental medicine (01-01-1995)
    “…Normal host cells are protected from the destructive action of complement by cell surface complement regulatory proteins. In humans, decay-accelerating factor…”
    Get full text
    Journal Article
  10. 10

    Tethered Polymer-Supported Planar Lipid Bilayers for Reconstitution of Integral Membrane Proteins: Silane-Polyethyleneglycol-Lipid as a Cushion and Covalent Linker by Wagner, Michael L., Tamm, Lukas K.

    Published in Biophysical journal (01-09-2000)
    “…There is increasing interest in supported membranes as models of biological membranes and as a physiological matrix for studying the structure and function of…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Psychology and survival by Phillips, D P, Ruth, T E, Wagner, L M

    Published in The Lancet (British edition) (06-11-1993)
    “…We examined the deaths of 28,169 adult Chinese-Americans, and 412,632 randomly selected, matched controls coded "white" on the death certificate…”
    Get more information
    Journal Article
  13. 13

    A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11 by MECK, Mandy M, WIERDL, Monika, WAGNER, Lars M, BURGER, Rebecca A, GUICHARD, Sylvie M, KRULL, Erik J, HARRIS, Linda C, POTTER, Philip M, DANKS, Mary K

    Published in Cancer research (Chicago, Ill.) (01-07-2001)
    “…Tumor cells that contaminate hematopoietic cell preparations contribute to the relapse of neuroblastoma patients who receive autologous stem cell rescue as a…”
    Get full text
    Journal Article
  14. 14

    Restless legs syndrome in childhood and adolescence by Walters, A S, Picchietti, D L, Ehrenberg, B L, Wagner, M L

    Published in Pediatric neurology (01-10-1994)
    “…Restless legs syndrome (RLS) is believed to be a condition primarily of middle to older age. However, it can have its onset in childhood. Five illustrative…”
    Get more information
    Journal Article
  15. 15

    Coadministration of Phenytoin and Felbamate: Evidence of Additional Phenytoin Dose‐Reduction Requirements Based on Pharmacokinetics and Tolerability with Increasing Doses of Felbamate by Sachdeo, R., Wagner, M. L., Sachdeo, S., Shumaker, R. C., Lyness, W. H., Rosenberg, A., Ward, D., Perhach, J. L.

    Published in Epilepsia (Copenhagen) (01-08-1999)
    “…Purpose: This open‐label study investigated the pharmacokinetic interaction of phenytoin (PHT) and felbamate (FBM). Methods: Ten subjects with epilepsy…”
    Get full text
    Journal Article
  16. 16

    Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis by PUGH, J. A, WAGNER, M. L, SAWYER, J, RAMIREZ, G, TULEY, M, FRIEDBERG, S. J

    Published in Diabetes care (01-08-1992)
    “…Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. J A Pugh , M L Wagner , J Sawyer , G Ramirez , M Tuley and S J…”
    Get full text
    Journal Article
  17. 17

    A 1.3-Mb interval map of equine homologs of HSA2 by Wagner, M L, Raudsepp, T, Goh, G, Agarwala, R, Schaffer, A A, Dranchak, P K, Brinkmeyer-Langford, C, Skow, L C, Chowdhary, B P, Mickelson, J R

    Published in Cytogenetic and genome research (01-01-2006)
    “…A comparative approach that utilizes information from more densely mapped or sequenced genomes is a proven and efficient means to increase our knowledge of the…”
    Get more information
    Journal Article
  18. 18

    Antiviral activity of Petiveria alliacea against the bovine viral diarrhea virus by Ruffa, M J, Perusina, M, Alfonso, V, Wagner, M L, Suriano, M, Vicente, C, Campos, R, Cavallaro, L

    Published in Chemotherapy (Basel) (01-07-2002)
    “…Natural products are a relevant source of antiviral drugs. Five medicinal plants used in Argentina have been assayed to detect inhibition of viral growth…”
    Get more information
    Journal Article
  19. 19

    Estimated prevalence of the Type 1 Polysaccharide Storage Myopathy mutation in selected North American and European breeds by McCue, M.E, Anderson, S.M, Valberg, S.J, Piercy, R.J, Barakzai, S.Z, Binns, M.M, Distl, O, Penedo, M.C.T, Wagner, M.L, Mickelson, J.R

    Published in Animal genetics (01-12-2010)
    “…The GYS1 gene mutation that is causative of Type 1 Polysaccharide Storage Myopathy (PSSM) has been identified in more than 20 breeds of horses. However, the…”
    Get full text
    Journal Article
  20. 20

    Discontinuation of phenytoin and carbamazepine in patients receiving felbamate by Wagner, M L, Graves, N M, Marienau, K, Holmes, G B, Remmel, R P, Leppik, I E

    Published in Epilepsia (Copenhagen) (01-05-1991)
    “…Five patients participated in a controlled discontinuation of phenytoin (PHT) and carbamazepine (CBZ) after a study in which all subjects had felbamate (FBM)…”
    Get more information
    Journal Article